HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Biomérieux Launches Free Mobile App to Aid Clinicians in Emergency and Critical Care Diagnostics

By HospiMedica International staff writers
Posted on 04 Mar 2022
Print article
Image: MYACUTECASE (Photo courtesy of bioMérieux)
Image: MYACUTECASE (Photo courtesy of bioMérieux)

A free mobile application aims to support clinicians in decision-making and monitoring of patients using emergency and critical care diagnostics. In hospitals, particularly for emergency cases, diagnostic options can be limited for patients with acute and complex pathologies. Clinicians need to rapidly and accurately assess and identify the correct therapeutic protocol for each patient. With the vast array of biomarkers available today, interpretation can be challenging but crucial to optimize patient care and help save lives. For correct interpretation of a particular in vitro diagnostics (IVD) test, it is of paramount importance to align the medical diagnostic and management decisions with corresponding guidelines, expert recommendations and best practices.

bioMérieux (Marcy-l'Étoile, France) has developed the first of a kind mobile application, MYACUTECASE that serves as an aid in the interpretation of VIDAS emergency and critical care biomarker tests. The first version of bioMérieux’s easy-to-use mobile application addresses four emergency and critical care assays, namely VIDAS D-Dimer Exclusion II, VIDAS NT-proBNP2, VIDAS B.R.A.H.M.S PCT, and VIDAS High sensitive Troponin I.

Through the application’s educational material, hospitals will be able to support continuous healthcare education through on-demand high medical value content regarding targeted disease states, corresponding diagnostic pathways, relevant biomarkers and their use in various situations. It combines within the same digital tool the entire information that one finds in the test’s package insert, the information brochure, various peer-reviewed national and international guidelines, and other relevant material.

MYACUTECASETM is registered as IVD software and has been co-developed with experts and target users. More than 20 clinicians were involved in designing and approving MYACUTECASE. The application is now available on Apple App Store for free, both in French and in English, and it is planned to evolve by including other test parameters or languages. In the future it will also be compatible with other OS such as Android.

“With MYACUTECASE, our goal is to help clinicians choose the right biomarker tests to order for a particular patient and facilitate the interpretation of results,” said Mark Miller, Executive Vice President, Chief Medical Officer. “A rapid and easy access to testing and disease information, expert guidelines and best practices will allow them to improve patient care and potentially to save lives.”

“MYACUTECASE is a very innovative application that will help labs and clinicians working together but also clinicians better interpreting insights from VIDAS emergency testing,” added Pierre Boulud, Chief Operating Officer, Clinical Operations. “Our data insight solutions are a strategic component of our offering. They bring unique opportunities to leverage the quality of diagnostics to enhance its medical value for the benefit of patients.”

Related Links:
bioMérieux 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Computerized Spirometer
DatospirAira

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Surgical Techniques

view channel
Image: The multi-sensing device can be implanted into blood vessels to help physicians deliver timely treatment (Photo courtesy of IIT)

Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health

Researchers have embarked on a project to develop a multi-sensing device that can be implanted into blood vessels like peripheral veins or arteries to monitor a range of bodily parameters and overall health status.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more